Submitted by Anonymous (not verified) on 18 May 2026 - 10:45
Orphan designation: serplulimab Treatment of small cell lung cancer, 20/02/2025 Withdrawn
Source:
Orphan designation: serplulimab Treatment of small cell lung cancer, 20/02/2025 Withdrawn